InvestorsObserver
×
News Home

Is Cutera, Inc. (CUTR) a Bad Choice in Medical Devices Monday?

Monday, November 20, 2023 09:57 AM | InvestorsObserver Analysts

Mentioned in this article

Is Cutera, Inc. (CUTR) a Bad Choice in Medical Devices Monday?

The 34 rating InvestorsObserver gives to Cutera, Inc. (CUTR) stock puts it near the middle of the Medical Devices industry. In addition to scoring higher than 36 percent of stocks in the Medical Devices industry, CUTR’s 34 overall rating means the stock scores better than 34 percent of all stocks.

Overall Score - 34
CUTR has an Overall Score of 34. Find out what this means to you and get the rest of the rankings on CUTR!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 34 would rank higher than 34 percent of all stocks.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Cutera, Inc. Stock Today?

Cutera, Inc. (CUTR) stock is down -5.19% while the S&P 500 has gained 0.22% as of 9:57 AM on Monday, Nov 20. CUTR has fallen -$0.12 from the previous closing price of $2.31 on volume of 96,462 shares. Over the past year the S&P 500 is higher by 14.53% while CUTR has fallen -94.91%. CUTR lost -$3.90 per share the over the last 12 months. Click Here to get the full Stock Report for Cutera, Inc. stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App